Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib plus exemestane versus placebo plus exemestane in hormone receptor-positive advanced or metastatic breast cancer
2007-005954-22Phase 2Completed
- Sponsor
- GSK
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in breast cancer comparing Pazopanib + exemestane with Placebo + exemestane (2 arms). Primary endpoint: Progression-free survival. Started May 2008; status: completed.
02
Drugs
pazopanibexemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2007-005954-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005954-22.